drugset / Trial / NCT00332904
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The study´s purpose is to investigate the effect of beta blockade or aldosterone antagonist therapy on oxygenation, peripheral and cardiac hemodynamics and humoral systems, in patients with liver cirrhosis.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-07
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propranolol | Small molecule | 80 mg | — |
| Comparator | Spironolactone | Small molecule | 200 mg | — |